{"id":"W3022456477","doi":"10.1016/j.msard.2020.102086","title":"Alemtuzumab and prescription medication use in the MS population","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Marshall-Smith Syndroom Research Foundation; Multiple Sclerosis International Federation; Stichting MS Research; American Academy of Neurology; Multiple Sclerosis Society of Canada; Michael Smith Health Research BC; Canada Foundation for Innovation; National Multiple Sclerosis Society","keywords":"Alemtuzumab; Medicine; Medical prescription; Polypharmacy; Multiple sclerosis; Population; Drug; Adverse effect; Pediatrics; Internal medicine; Psychiatry; Pharmacology; Environmental health","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007443186,0.0001694002,0.0004163262,0.0008687281,0.0003163163,0.0009561792,0.0002439484,0.0005397409,0.001171054],"category_scores_gemma":[0.0043908,0.0002225914,0.0005955038,0.001495466,0.0002330099,0.0005127652,0.0003257437,0.0005678777,0.0001583637],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002915312,"about_ca_system_score_gemma":0.0003269163,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006413777,"about_ca_topic_score_gemma":0.004946225,"domain_scores_codex":[0.9992254,0.0003688505,0.00009560459,0.0001153069,0.0001037109,0.00009109231],"domain_scores_gemma":[0.9983032,0.0005196679,0.0007812642,0.000112496,0.0001006513,0.0001827335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000448571,0.00007064795,0.9969139,0.00002149295,0.0002809551,0.0001108676,0.0001022819,0.00002316898,0.0002114254,0.00002900974,0.0001001781,0.001687427],"study_design_scores_gemma":[0.00001462151,0.0001179388,0.9988029,0.00001131595,0.0001344592,0.0002889867,0.0002232069,0.00008421172,0.00005469382,0.00002698724,0.0002367242,0.000003938526],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977119,0.001454802,0.00002244799,0.00009926606,0.000007958939,0.000002159176,0.0002282946,0.000002266036,0.0004708342],"genre_scores_gemma":[0.9992108,0.0004477835,0.00001419062,0.0000458801,0.00002113424,0.000003572221,0.0001053138,0.000001198793,0.0001501742],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006413777,"threshold_uncertainty_score":0.01275289,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06380809541472414,"score_gpt":0.2727158265422622,"score_spread":0.208907731127538,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}